AT385199B - METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE - Google Patents

METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE

Info

Publication number
AT385199B
AT385199B AT0341582A AT341582A AT385199B AT 385199 B AT385199 B AT 385199B AT 0341582 A AT0341582 A AT 0341582A AT 341582 A AT341582 A AT 341582A AT 385199 B AT385199 B AT 385199B
Authority
AT
Austria
Prior art keywords
producing
active substance
pharmaceutical preparation
substance release
delayed active
Prior art date
Application number
AT0341582A
Other languages
German (de)
Other versions
ATA341582A (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ATA341582A publication Critical patent/ATA341582A/en
Application granted granted Critical
Publication of AT385199B publication Critical patent/AT385199B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0341582A 1981-09-14 1982-09-13 METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE AT385199B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14

Publications (2)

Publication Number Publication Date
ATA341582A ATA341582A (en) 1987-08-15
AT385199B true AT385199B (en) 1988-02-25

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0341582A AT385199B (en) 1981-09-14 1982-09-13 METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE

Country Status (11)

Country Link
JP (1) JPS5857315A (en)
AT (1) AT385199B (en)
BE (1) BE894376A (en)
BG (1) BG60526B2 (en)
CH (1) CH652025A5 (en)
DE (1) DE3232873A1 (en)
FR (1) FR2512676B1 (en)
GB (1) GB2105590B (en)
IT (1) IT1158048B (en)
MX (1) MX9203173A (en)
NL (1) NL190746C (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (en) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd Medicinal drug and its preparation
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (en) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Floating sustained release therapeutic compositions
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (en) * 1986-08-26 1989-12-11 Lejus Medical Ab A MULTIPLE-UNIT DOS COMPOSITION OF L-DOPA
DE3642668A1 (en) * 1986-12-13 1988-06-23 Kamprad Joachim Painkillers for people
DE3875716D1 (en) * 1987-12-31 1992-12-10 Asta Medica Ag SYNERGISTIC COMBINATION OF DECARBOXYLASE INHIBITORS AND L-DOPA PELLETS.
EP0497977B1 (en) * 1989-10-26 1995-03-15 Nippon Shinyaku Company, Limited Gastric preparation
DE4101873C2 (en) 1991-01-23 1993-12-09 Isis Pharma Gmbh Orally administrable drug form for the treatment of central dopamine deficiency states
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (en) * 1992-11-30 1992-11-30 Christer Nystroem DISPERSA SYSTEM MEDICINAL PRODUCT
CA2175225C (en) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Gelatin capsule fill able to foam
WO1995011668A1 (en) * 1993-10-29 1995-05-04 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
KR20050083750A (en) * 2002-10-11 2005-08-26 디포메드 디벨롭먼트 리미티드 Gastr0-retentive levodopa delivery form
DE102004039196B4 (en) 2004-08-12 2008-07-31 Dr.Kamprad Kg New formulation for L-tryptophan
USD627230S1 (en) 2008-05-22 2010-11-16 Colgate-Palmolive Company Container
DE102010023828A1 (en) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmaceutical preparation containing entacapone, levodopa and carbidopa
USD673861S1 (en) * 2012-03-28 2013-01-08 S.C. Johnson & Son, Inc. Dispensing system
DE102014003744A1 (en) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Product for oral administration to humans or animals with microstructured encapsulated ingredients, and apparatus for making such a product, and method of making the same
DE102022103658A1 (en) 2022-02-16 2023-08-17 Joachim Kamprad Drug composition containing L-tryptophan (L-Try) and L-5-hydroxytryptophan (5-HTP) and a peripheral degradation inhibitor

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
DE2131616A1 (en) * 1970-07-24 1972-02-03 Hoffmann La Roche Pharmaceutical preparation
DE2305209A1 (en) * 1972-02-14 1973-08-23 Hoffmann La Roche PHARMACEUTICAL PREPARATION
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (en) * 1961-06-16 1966-03-31 Hoffmann La Roche Process for the preparation of substituted hydrazines
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
GB1430684A (en) * 1972-06-26 1976-03-31 Lowey H Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
DE2131616A1 (en) * 1970-07-24 1972-02-03 Hoffmann La Roche Pharmaceutical preparation
DE2305209A1 (en) * 1972-02-14 1973-08-23 Hoffmann La Roche PHARMACEUTICAL PREPARATION
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations

Also Published As

Publication number Publication date
DE3232873A1 (en) 1983-03-31
IT1158048B (en) 1987-02-18
NL190746B (en) 1994-03-01
BG60526B2 (en) 1995-07-28
FR2512676B1 (en) 1987-01-23
IT8223147A1 (en) 1984-03-07
BE894376A (en) 1983-03-14
IT8223147A0 (en) 1982-09-07
MX9203173A (en) 1992-07-01
ATA341582A (en) 1987-08-15
NL190746C (en) 1994-08-01
FR2512676A1 (en) 1983-03-18
JPH0341447B2 (en) 1991-06-24
GB2105590B (en) 1985-05-30
NL8203343A (en) 1983-04-05
JPS5857315A (en) 1983-04-05
CH652025A5 (en) 1985-10-31
GB2105590A (en) 1983-03-30

Similar Documents

Publication Publication Date Title
AT385199B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH DELAYED ACTIVE SUBSTANCE RELEASE
AT377438B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION
AT381639B (en) METHOD FOR PRODUCING PHARMACEUTICAL TABLETS WITH DELAYED ACTIVE RELEASE RELEASE
ATA151587A (en) METHOD FOR PRODUCING A PHARMACEUTICAL CAPSULE FOR ORAL ADMINISTRATION WITH DELAYED ACTIVE SUBSTANCE RELEASE OR. COMBINED DELAYED / RAPID RELEASE OF ACTIVE SUBSTANCE
ATA115186A (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION WITH A NON-PROTECTING EFFECT
AT381638B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION
ATA164187A (en) METHOD FOR PRODUCING A PHARMACEUTICAL POWDER
AT371708B (en) METHOD FOR PRODUCING PHARMACEUTICAL UNIT DOSAGE FORMS
ATA900385A (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION USING AN ANALGETIC AND ANTI-INFLAMMATORY NON-STEROID ACTIVE SUBSTANCE
DE3687502D1 (en) METHOD FOR PRODUCING A WATERPROOF SUBSTANCE.
DE68918016D1 (en) Process for the preparation of a dimethyltetralin.
AT365451B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION CONTAINING ISOSORBIDE DINITRATE
ATA245988A (en) METHOD FOR PRODUCING ANALGETIC AND ANTI-INFLAMMATORY PHARMACEUTICAL PREPARATION
AT368888B (en) AQUEOUS CARRIER SYSTEM FOR PRODUCING PHARMACEUTICAL PREPARATIONS AND METHOD FOR PRODUCING A CARRIER SYSTEM OR A PHARMACEUTICAL COMPOSITION
DE3381345D1 (en) METHOD FOR PRODUCING A COMBINED PHARMACEUTICAL COMPOSITION IN A GRANULAR HETEROGENIC DOSE FORM WITH INCREASED BIOAVAILABILITY.
AT351159B (en) METHOD FOR PRODUCING A CEPHALEXIN PREPARATION WITH PARTIALLY DELAYED ACTIVE SUBSTANCE DELIVERY FOR ORAL ADMINISTRATION IN PEOPLE
ATA18588A (en) METHOD FOR PRODUCING A PHARMACEUTICAL DRY PREPARATION CONTAINING A DICLOFENAC SALT
AT374682B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION
AT374365B (en) METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATION
ATA216079A (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT363174B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
ATA207887A (en) METHOD FOR PRODUCING A PHARMACEUTICAL NICORANDIL PREPARATION FOR PERCUTANIC ABSORPTION
ATA92982A (en) METHOD FOR PRODUCING A PHARMACEUTICAL PARENTERAL DOSING UNIT OF NA-PIPERACILLIN
ATA367583A (en) METHOD FOR PRODUCING PHARMACEUTICAL TABLETS
AT378916B (en) METHOD FOR PRODUCING A PHARMACEUTICAL COMBINATION PREPARATION

Legal Events

Date Code Title Description
ELA Expired due to lapse of time